Julia F. Charles MD PhD
Assistant Professor, Harvard Medical School Associate Physician, Brigham and Women's Hospital
Join to View Full Profile
60 Fenwood Road, Room 5016LDepartments of Orthopaedic Surgery and MedicineBoston, MA 02115
Phone+1 617-732-5325
Fax+1 617-732-5766
Dr. Charles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Rheumatology, 2004 - 2007
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2004
- University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
- FL State Medical License 2022 - 2027
- MA State Medical License 2011 - 2026
- NH State Medical License 2023 - 2025
- CA State Medical License 2004 - 2011
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Maresin 1-LGR6 axis mitigates inflammation and posttraumatic osteoarthritis after transection of the anterior cruciate ligament in mice.Chilan B G Leite, Hannah P Fricke, Luciana P Tavares, Robert Nshimiyimana, Julie Mekhail
Osteoarthritis and Cartilage. 2025-03-24 - Effective and Engaging Active Learning in the Medical School Classroom: Lessons from Case-Based Collaborative Learning.Henrike C Besche, Randall W King, Keri M Shafer, Sarah E Fleet, Julia F Charles
Journal of Medical Education and Curricular Development. 2025-01-28 - Bone loss with aging is independent of gut microbiome in mice.Xiaomeng You, Jing Yan, Jeremy Herzog, Sabah Nobakhti, Ross Campbell
Bone Research. 2024-11-11
Journal Articles
- Peripartum Fluoxetine Reduces Maternal Trabecular Bone Post-Weaning and Elevates Mammary Gland Serotonin and PTHrPJulia Charles, MD, Endocrinology
- Costimulatory blockade to prevent osteoclastogenesis, inflammation or both?Charles, J.F. and M.C. Nakamura, Bone Key
Grant Support
- Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and backBRIGHAM AND WOMEN'S HOSPITAL2022–2027
- Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and backBRIGHAM AND WOMEN'S HOSPITAL2022–2027
- Osteoclasts or RANKL: Which is the critical target in treatment of fibrous dysplasia bone lesions?BRIGHAM AND WOMEN'S HOSPITAL2024–2026
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: